Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.

Gene therapy - 1 Jan 1994

Liu J, Woffendin C, Yang Z Y, Nabel G J

Abstract excerpt

Infection by the human immunodeficiency virus (HIV) has remained refractory to treatment, and molecular genetic interventions have been developed for the treatment of the acquired immunodeficiency syndrome (AIDS). Previous studies have focused on the development of gene products which inhibit productive HIV replication, including transdominant proteins, RNA decoys and ribozymes. In this report, we show that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cells, Cultured
Share to Genes, Dominant
Share to Genetic Vectors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Plasmids

Share to T-Lymphocytes

Share to Transfection

Source

Identifiers

PMID: 7584057

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.PMID 7584057Read ↗

A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.Semantic proximity Read ↗

Inhibition of HIV/SIV replication by dominant negative Gag mutants.Semantic proximity Read ↗

The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.Semantic proximity Read ↗

A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection.Semantic proximity Read ↗

Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.Semantic proximity Read ↗

Inhibition of Tat-mediated transactivation and HIV replication with Tat mutant and repressor domain fusion proteins.Semantic proximity Read ↗

Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication.Semantic proximity Read ↗

Potent inhibition of HIV-1 replication by a Tat mutant.Semantic proximity Read ↗

TAR decoys and trans-dominant gag mutant for HIV-1 gene therapy.Semantic proximity Read ↗

Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant Rev.Semantic proximity Read ↗

Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein.Semantic proximity Read ↗

Construction and characterization of a potent HIV-2 Tat transdominant mutant protein.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.